KR960003732A - 상처 치료용 멸균 겔 조성물 - Google Patents
상처 치료용 멸균 겔 조성물 Download PDFInfo
- Publication number
- KR960003732A KR960003732A KR1019950020944A KR19950020944A KR960003732A KR 960003732 A KR960003732 A KR 960003732A KR 1019950020944 A KR1019950020944 A KR 1019950020944A KR 19950020944 A KR19950020944 A KR 19950020944A KR 960003732 A KR960003732 A KR 960003732A
- Authority
- KR
- South Korea
- Prior art keywords
- aqueous gel
- gel composition
- alginate
- composition
- polyhydric alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
- A61L2/07—Steam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0071—Plasticisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
Abstract
본 발명은 알기네이트 2 내지 10% w/v 및 다가 알콜 25 내지 40% w/v를 포함하는 상처 드레싱에 사용하기 위한 사실상 멸균 상태의 수성 겔 조성물을 제공한다. 알기네이트는 바람직하게는 나트륨 알기네이트 및/또는 칼륨 알기네이트이다. 다가 알콜은 바람직하게는 프로필렌 글리콜 및 헥실렌 글리콜이다.
또한 상기의 조성을 갖는 수성 겔을 제공하는 단계 및 수성 겔을 멸균시키는 단계를 포함하여, 이러한 수성 겔을 제조하는 방법을 제공한다. 바람직하게는, 수성 겔은 가열함으로써 멸균시킨다.
Description
내용없음
Claims (15)
- 알기네이트 2 내지 10% w/v 및 다가 알콜 25 내지 40% w/v를 포함하는 상처 드레싱에 사용하기 위한 사실상 멸균 상태의 수성 겔 조성물.
- 제1항에 있어서, 알기네이트 3 내지 6% w/v 포함하는 수성 겔 조성물.
- 제1항 또는 제2항에 있어서, 알기네이트가 수용성 알기네이트 염인 수성 겔 조성물.
- 제1항 내지 제3항 중의 어느 한 항에 있어서, 다가 알콜을 20 내지 35% w/v 포함하는 수성 겔 조성물.
- 제1항 내지 제4항 중의 어느 한 항에 있어서, 다가 알콜이 하나 이상의 C3-C62가 알콜을 포함하는 수성 겔 조성물.
- 제5항에 있어서, C3-C62가 알콜이 프로필렌 글리콜 및 헥실렌 글리콜로 이루어진 그룹으로부터 선택되는 수성 겔 조성물.
- 제1항 내지 제6항 중의 어느 한 항에 있어서, 약제학적으로 활성인 화합물 0.01 내지 10% w/v, 바람직하게는 0.1 내지 5% w/v를 추가로 포함하는 수성 겔 조성물.
- 제7항에 있어서, 약제학적으로 활성인 화합물이 방부제, 항생제, 진통제, 글리코스아미노글리칸, 비타민, 항체, 효소, 지혈제, 시토킨, 염증제, 소염제, 스테로이드 또는 성장 인자를 포함하는 수성 겔 조성물.
- 제1항 내지 제8항 중의 어느 한 항에 있어서, 용해 염 0.1 내지 5% w/v를 추가로 포함하는 수성 겔 조성물.
- 제9항에 있어서, 용해 염이 염화나트륨 또는 인산나트륨 염을 포함하는 수성 겔 조성물.
- 알기네이트 2 내지 10% w/v 및 다가 알콜 15 내지 40% w/v를 포함하는 수성 겔을 제공하는 단계 및 수성 겔을 멸균시키는 단계를 포함하여, 상처 드레싱에 사용하기 위한 사실상 멸균 상태의 겔을 제조하는 방법.
- 제11항에 있어서, 멸균 단계를 FO4의 멸균치를 제공하기에 충분한 온도에서 및 FO4의 멸균치를 제공하기에 충분한 시간 동안 가열함으로써 수행하는 방법.
- 제12항에 있어서, 가열-멸균 단계를 오토클레이브 속에서 가압하에서 수행하는 방법.
- 제11항 내지 제13항 중의 어느 한 항에 있어서, 수성 겔의 조성이 제2항 내지 제12항 중의 어느 한 항에서 청구한 조성과 같은 방법.
- 제11항 내지 제14항 중의 어느 한 항에 있어서, 멸균 단계 전에 수성 겔을 밀봉 패키지 내로 삽입시키는 단계를 추가로 포함하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9414454.0 | 1994-07-18 | ||
GB9414454A GB2291348B (en) | 1994-07-18 | 1994-07-18 | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
Publications (1)
Publication Number | Publication Date |
---|---|
KR960003732A true KR960003732A (ko) | 1996-02-23 |
Family
ID=10758502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950020944A KR960003732A (ko) | 1994-07-18 | 1995-07-18 | 상처 치료용 멸균 겔 조성물 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5693624A (ko) |
EP (1) | EP0693292B1 (ko) |
JP (1) | JPH08187280A (ko) |
KR (1) | KR960003732A (ko) |
AT (1) | ATE209510T1 (ko) |
AU (1) | AU696405B2 (ko) |
BR (1) | BR9503349A (ko) |
CA (1) | CA2153947A1 (ko) |
DE (1) | DE69524152T2 (ko) |
FI (1) | FI953453A (ko) |
GB (1) | GB2291348B (ko) |
NO (1) | NO952824L (ko) |
TW (1) | TW443932B (ko) |
ZA (1) | ZA955607B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050086324A (ko) * | 2004-02-25 | 2005-08-30 | 김아란 | 3%부터 9%까지 셀라인 (염수) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9701552D0 (en) * | 1997-01-25 | 1997-03-12 | Bristol Myers Squibb Co | Multi-dose wound gel |
US6605751B1 (en) | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
GB2344519B (en) * | 1998-12-07 | 2004-05-19 | Johnson & Johnson Medical Ltd | Sterile therapeutic compositions |
US6197061B1 (en) | 1999-03-01 | 2001-03-06 | Koichi Masuda | In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
DE60028415T2 (de) | 1999-12-30 | 2007-06-06 | Acrymed, Portland | Methode und zusammensetzungen für verbesserte abgabevorrichtungen |
FR2827764B1 (fr) * | 2001-07-27 | 2005-08-19 | Oreal | Composition, notamment cosmetique, renfermant un steroide et un glycol |
KR100944204B1 (ko) * | 2001-09-15 | 2010-02-26 | 러쉬 유니버시티 메디컬 센터 | 중층 연골 조직 및 그것을 조작하는 방법 |
US20030165473A1 (en) * | 2001-11-09 | 2003-09-04 | Rush-Presbyterian-St. Luke's Medical Center | Engineered intervertebral disc tissue |
JP2005512735A (ja) * | 2001-12-21 | 2005-05-12 | コロプラスト アクティーゼルスカブ | 創傷ケア器具 |
US20040001878A1 (en) * | 2002-06-26 | 2004-01-01 | Deroyal Industries, Inc. | Infused wound care dressings |
US8486426B2 (en) | 2002-07-29 | 2013-07-16 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for treatment of dermal conditions |
US20050085749A1 (en) * | 2003-10-15 | 2005-04-21 | Kevin Baerwalde | Device for therapeutic treatment of foot, heel, and/or like pain |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
EP1574222B1 (en) * | 2004-03-12 | 2011-02-09 | Cipla Ltd. | Sterilization process for steroids |
IN266973B (ko) | 2004-07-30 | 2007-07-06 | Kimberly Clark Co | |
CN101010004B (zh) | 2004-07-30 | 2012-10-03 | 金伯利-克拉克环球有限公司 | 抗微生物的装置和组合物 |
US8361553B2 (en) | 2004-07-30 | 2013-01-29 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for metal nanoparticle treated surfaces |
WO2006034249A2 (en) | 2004-09-20 | 2006-03-30 | Acrymed, Inc. | Antimicrobial amorphous compositions |
DE102006001954B4 (de) * | 2006-01-16 | 2013-01-03 | Lohmann & Rauscher Gmbh & Co. Kg | Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung |
EP2008663A4 (en) * | 2006-03-22 | 2010-03-31 | Cellgentech Inc | LIQUID COMPOSITION FOR EXTERNAL ADMINISTRATION AND PREPARATION FOR EXTERNAL ADMINISTRATION FOR THE TREATMENT OF SKIN DISEASES |
WO2007127236A2 (en) | 2006-04-28 | 2007-11-08 | Acrymed, Inc. | Antimicrobial site dressings |
US10232064B2 (en) | 2006-10-04 | 2019-03-19 | National Cheng Kung University | Method for sterilizing biological materials |
JP5661985B2 (ja) | 2006-12-27 | 2015-01-28 | 帝人ファーマ株式会社 | 無菌性水性懸濁製剤 |
US8283338B2 (en) * | 2007-11-30 | 2012-10-09 | Kao Corporation | GIP secretion inhibitor |
KR101511405B1 (ko) * | 2008-02-25 | 2015-04-15 | 데이고꾸세이약꾸가부시끼가이샤 | 하이드로겔 창상피복재 |
GB2460815A (en) | 2008-04-04 | 2009-12-16 | Kays Medical | A sterilisable gel formulation comprising calcium gluconate |
WO2010117266A1 (en) * | 2009-04-06 | 2010-10-14 | Broockeville Corporation N.V. | In situ gelling alginate systems |
WO2011052613A1 (ja) | 2009-10-26 | 2011-05-05 | 日産化学工業株式会社 | 化粧料及び皮膚外用剤、並びに医療用機器 |
WO2011112082A1 (en) | 2010-03-11 | 2011-09-15 | Bender Analytical Holding B.V. | Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
AU2011304133A1 (en) | 2010-09-17 | 2013-03-28 | Teikoku Seiyaku Co., Ltd. | Method for using hydrogel sheet for treating wound |
RU2454242C1 (ru) * | 2010-10-12 | 2012-06-27 | Борис Карпович Гаврилюк | Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения |
WO2011133064A1 (ru) * | 2010-10-12 | 2011-10-27 | Gavrilyuk Boris Karpovich | Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения |
EP2747760B1 (en) | 2011-09-15 | 2015-07-15 | Bender Analytical Holding B.V. | Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
JP6871855B2 (ja) | 2014-10-14 | 2021-05-19 | サムエル リンチ, | 創傷を処置するための組成物 |
RU2616250C1 (ru) * | 2015-12-01 | 2017-04-13 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ получения биоактивной сорбционно-гелиевой композиции |
DE102019216424A1 (de) * | 2019-10-24 | 2021-04-29 | Mahle International Gmbh | Ölkühlermodul |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
US4393048A (en) * | 1980-02-15 | 1983-07-12 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for wounds |
US4391799A (en) * | 1980-02-15 | 1983-07-05 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for treating white phosphorus burn wounds |
GB2075837B (en) * | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
FR2489145A1 (fr) * | 1980-09-04 | 1982-03-05 | Geistlich Soehne Ag | Compositions pharmaceutiques accelerant la guerison de blessures |
DE3376957D1 (en) * | 1982-06-24 | 1988-07-14 | Robert Alan Smith | Pharmaceutical gel composition |
JPS5948413A (ja) * | 1982-09-14 | 1984-03-19 | Grelan Pharmaceut Co Ltd | クリダナクを含有する消炎鎮痛外用剤 |
US4525348A (en) * | 1983-12-19 | 1985-06-25 | Yoshitomi Pharmaceutical Industries, Ltd. | Pranoprofen gelled ointment |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
US5264422A (en) * | 1986-06-30 | 1993-11-23 | Fidia S.P.A. | Esters of alginic acid with steroidal alcohols |
US5288479A (en) * | 1989-01-17 | 1994-02-22 | Sterling Drug, Inc. | Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof |
DE3903672C1 (ko) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
IT1248666B (it) * | 1990-05-30 | 1995-01-26 | Fidia Spa | Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee |
JP3254013B2 (ja) * | 1991-09-10 | 2002-02-04 | ジョンソン・アンド・ジョンソン・メディカル・インコーポレイテッド | 包帯材料およびその製造方法 |
GB9209327D0 (en) * | 1992-04-30 | 1992-06-17 | Johnson & Johnson Medical | Freeze-dried pad |
GB9218749D0 (en) * | 1992-09-04 | 1992-10-21 | Courtaulds Plc | Alginate gels |
GB2276819B (en) * | 1993-03-23 | 1996-12-11 | Johnson & Johnson Medical | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol |
-
1994
- 1994-07-18 GB GB9414454A patent/GB2291348B/en not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/462,243 patent/US5693624A/en not_active Expired - Lifetime
- 1995-07-05 ZA ZA955607A patent/ZA955607B/xx unknown
- 1995-07-11 AU AU24928/95A patent/AU696405B2/en not_active Ceased
- 1995-07-14 CA CA002153947A patent/CA2153947A1/en not_active Abandoned
- 1995-07-17 EP EP95304958A patent/EP0693292B1/en not_active Expired - Lifetime
- 1995-07-17 DE DE69524152T patent/DE69524152T2/de not_active Expired - Lifetime
- 1995-07-17 AT AT95304958T patent/ATE209510T1/de not_active IP Right Cessation
- 1995-07-17 NO NO952824A patent/NO952824L/no not_active Application Discontinuation
- 1995-07-17 BR BR9503349A patent/BR9503349A/pt not_active Application Discontinuation
- 1995-07-17 JP JP7201830A patent/JPH08187280A/ja active Pending
- 1995-07-17 FI FI953453A patent/FI953453A/fi unknown
- 1995-07-18 KR KR1019950020944A patent/KR960003732A/ko not_active Application Discontinuation
- 1995-08-11 TW TW084108358A patent/TW443932B/zh active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050086324A (ko) * | 2004-02-25 | 2005-08-30 | 김아란 | 3%부터 9%까지 셀라인 (염수) |
Also Published As
Publication number | Publication date |
---|---|
DE69524152D1 (de) | 2002-01-10 |
EP0693292B1 (en) | 2001-11-28 |
EP0693292A1 (en) | 1996-01-24 |
BR9503349A (pt) | 1996-02-27 |
GB9414454D0 (en) | 1994-09-07 |
CA2153947A1 (en) | 1996-01-19 |
JPH08187280A (ja) | 1996-07-23 |
US5693624A (en) | 1997-12-02 |
ATE209510T1 (de) | 2001-12-15 |
FI953453A (fi) | 1996-01-19 |
NO952824L (no) | 1996-01-19 |
DE69524152T2 (de) | 2002-05-16 |
NO952824D0 (no) | 1995-07-17 |
ZA955607B (en) | 1997-01-06 |
AU2492895A (en) | 1996-02-01 |
GB2291348B (en) | 1999-01-20 |
TW443932B (en) | 2001-07-01 |
AU696405B2 (en) | 1998-09-10 |
GB2291348A (en) | 1996-01-24 |
FI953453A0 (fi) | 1995-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960003732A (ko) | 상처 치료용 멸균 겔 조성물 | |
US4604384A (en) | Pharmaceutical gel composition | |
CA2312558C (en) | Collagen containing tissue adhesive | |
UA41989C2 (uk) | Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри | |
EP3445389B1 (en) | Formulations for debridement of chronic wounds | |
DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
US5814331A (en) | Process for inhibiting pathogenic bacteria in the oral cavity and for binding peptide growth factors on surfaces | |
DE3872472D1 (de) | Neue heilsalbe, verfahren zu ihrer herstellung, unter verwendung dieser heilsalbe hergestellte applikationsformen sowie deren herstellung. | |
JP2001017533A (ja) | 皮膚潰瘍補填修復材料 | |
AU558482B2 (en) | Pharmaceutical gel composition | |
DE69115890D1 (de) | Sterilisierende zusammensetzung | |
UA29143A (uk) | Спосіб лікування гнійної інфекції |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |